Poalmi Pharmaceuticals Private Limited
About Poalmi Pharmaceuticals Private Limited
Data last updated:
Poalmi Pharmaceuticals Private Limited is a private limited company based in Patna, Bihar, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 15 September 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U51101BR2014PTC022930. Its GSTIN is 10AAHCP8406H1ZN (Bihar).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹8 Lakh. It is led by directors Sudhir Kumar Mallik (Whole-Time Director) and Ashutosh Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Patna, Bihar.
As per the financials filed for FY 2025, the company reported a revenue of ₹95.13 Lakh, a growth of 3% compared to the previous year. For the same year it recorded a net loss of ₹98,575 (net margin -1%) and EBITDA of -₹57,409 (EBITDA margin -0.6%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years and 6% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Poalmi Pharmaceuticals Private Limited's registered office is in Patna, Bihar. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH/O – Radha Krishna Prabhat First Floor, Near Buddha Dental College & Hospital Mahatma Gandhi Nagar, Patna, Bihar, India – 800020
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Poalmi Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Poalmi Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Poalmi Pharmaceuticals Private Limited, buy the company report.
Financials of Poalmi Pharmaceuticals Private Limited
FY 2025 filings availablePoalmi Pharmaceuticals Private Limited reported revenue of ₹95.13 Lakh (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 3% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 6%. EBITDA fell 66% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹57,409 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹98,575 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.6% | ||||
| Net Profit Margin | -1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Poalmi Pharmaceuticals Private Limited, buy the company report.
Board of directors of Poalmi Pharmaceuticals Private Limited
Poalmi Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashutosh Kumar Also directs: Srivu Life Science Private Limited | Director | 15 Sep 2014 | 12 Years 1 Months | Current |
| Sudhir Kumar Mallik | Whole-Time Director | 10 Dec 2016 | 9 Years 10 Months | Current |
Peer comparison
Poalmi Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zealous Pharmaceuticals Private Limited | ₹95.71 Lakh (FY 2025) | 9.0% | Bhopal, Madhya Pradesh, India | |||
| Lusian Pharmaceuticals Private Limited | ₹95.53 Lakh (FY 2025) | 40.0% | Dehradun, Uttarakhand, India | |||
| Poalmi Pharmaceuticals Private Limitedthis company | ₹95.13 Lakh (FY 2025) | -₹98,575 | -1% | 3.0% | Patna, Bihar, India | |
| Charissa Psion Pharmaceuticals Private Limited | ₹95.08 Lakh (FY 2018) | -25.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Poalmi Pharmaceuticals Private Limited, buy the company report.
Auditor
Poalmi Pharmaceuticals Private Limited is audited by RICHA PRAMOD & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RICHA PRAMOD & ASSOCIATES | FY 2017 | 428914 |
Shareholding
The shareholding of Poalmi Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Poalmi Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Poalmi Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Poalmi Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Poalmi Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAHCP8406H1ZN | Bihar | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Poalmi Pharmaceuticals Private Limited, buy the company report.
Recent activity
Poalmi Pharmaceuticals Private Limited has 5 board changes on record since 2014: 2 appointments and 3 cessations. The latest: Sudhir Kumar Mallik was appointed as Whole-Time Director on 10 Dec 2016.
Frequently asked questions
Poalmi Pharmaceuticals is an active private limited company based in Patna, Bihar, India. The company works in wholesale, within the trading industry. It was incorporated on 15 September 2014 (12+ years old) and is registered under CIN U51101BR2014PTC022930.
Poalmi Pharmaceuticals has 2 current directors:
- Sudhir Kumar Mallik - Whole-Time Director
- Ashutosh Kumar - Director
The latest financial statements of Poalmi Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Poalmi Pharmaceuticals is 10AAHCP8406H1ZN, registered in Bihar.
The CIN (Corporate Identification Number) of Poalmi Pharmaceuticals is U51101BR2014PTC022930. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Poalmi Pharmaceuticals was incorporated on 15 September 2014, making it 12+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Poalmi Pharmaceuticals by revenue are Zealous Pharmaceuticals Private Limited, Lusian Pharmaceuticals Private Limited, Charissa Psion Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Sudhir Kumar Mallik was appointed as Whole-Time Director on 10 Dec 2016. Kumari Suman Singh ceased to be Additional Director on 05 Dec 2016. Kamlesh Kumar Singh ceased to be Director on 15 Apr 2015. Poalmi Pharmaceuticals has 5 board changes on record in total.
The registered office of Poalmi Pharmaceuticals is at HO – Radha Krishna Prabhat First Floor, Near Buddha Dental College & Hospital Mahatma Gandhi Nagar, Patna, Bihar, India – 800020.
Poalmi Pharmaceuticals operates in the trading industry, in the wholesale segment.
The compliance status of Poalmi Pharmaceuticals is compliant as of 25 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
